Edmonton, Alberta - TheNewswire - July 17, 2023 -  Innovotech (IOT:TSXV) has appointed Julie Wright as a director of the Company effective immediately.  

Wright is President of (W)right On Communications Inc, an award-winning integrated strategic communications firm she founded in 1998 with a head office in San Diego, Calif.  Her industry experience spans the cleantech, energy, healthcare, high-tech, life sciences, manufacturing, tourism and travel sectors, among others, with clients ranging from startups through Fortune 500 companies.  

Wright will be granted 50,000 incentive stock options at $0.10 exercisable over five years.

Wright currently serves on the Board of Directors of CanBiocin Inc., a privately-held Edmonton-based companion animal and livestock probiotic innovator, and as chair of Vancouver-based Lonsdale Capital Corporation. She is a director and past chair of the San Diego North Economic Development Council and a current director of Cal Travel, the advocacy organization for California’s travel and tourism industry.

Wright holds a Bachelor of Arts degree from the University of British Columbia and a Master of Journalism degree from the Graduate School of Journalism at the University of Western Ontario.  She is a graduate of the Governance Academy of the Corporate Director’s Forum.

About Innovotech

Innovotech is a Canadian biotechnology company owning proprietary intellectual property, conducting contract research, and owning and providing proprietary devices for testing in multiple applications in microbiology.  Innovotech can be found online at www.innovotech.ca.

James G. Timourian

President

Innovotech Inc.

This document may contain forward-looking statements that are predictive in nature and subject to risks and uncertainties that cannot be predicted or quantified; consequently, actual results may differ materially from past results and those expressed or implied by any forward-looking statements. Factors that could cause or contribute to such risks or uncertainties include, but are not limited to: the regulatory environment including the difficulty of predicting regulatory outcomes; changes in the value of the Canadian dollar; the Company’s reliance on a small number of customers including government organizations; fluctuations in operating results; government policies or actions; progress and cost of clinical trials; reliance on key strategic relationships; uncertainty related to intellectual property protection and potential costs associated with its defense; the Company’s exposure to lawsuits and other matters beyond the control of management. Should known or unknown risks or uncertainties materialize, or should management’s assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly make or update any forward-looking statements, except as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.